{"database": "lobbying", "table": "lobbying_activities", "rows": [[2422778, "bb865ecd-a3f1-4031-a24f-e6b6ca472ae8", "Q1", "TAUZIN STRATEGIC NETWORKS", 400786367, "TAUZIN CONSULTANTS (ON BEHALF OF SCILEX HOLDING COMPANY)", 2020, "first_quarter", "MMM", "Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2020-04-10T10:50:17.207000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2422778"], "units": {}, "query_ms": 0.46429000212810934, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}